3993.HK
China Molybdenum Co., Ltd. [3993.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3993.HK Stock Summary
Top 10 Correlated ETFs
3993.HK
Top 10 Correlated Stocks
3993.HK
In the News
3993.HK Financial details
Company Rating
Strong Buy
Market Cap
199B
Income
3.2B
Revenue
172.2B
Book val./share
2.55
Cash/share
2.04
Dividend
0.09
Dividend %
2.14%
Employees
12K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
27.16
Forward P/E
-
PEG
-7.16
P/S
0.64
P/B
1.6
P/C
3.72
P/FCF
-15.6
Quick Ratio
0.92
Current Ratio
1.56
Debt / Equity
1.08
LT Debt / Equity
0.34
-
-
EPS (TTM)
0.15
EPS next Y
-
EPS next Q
-
EPS this Y
16.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.92%
Revenue last 5Y
46.13%
Revenue Q/Q
5.92%
EPS Q/Q
346.11%
-
-
-
-
SMA20
27.21%
SMA50
73.15%
SMA100
70.78%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
6%
ROC
0.05%
Gross Margin
7%
Oper. Margin
4%
Profit Margin
2%
Payout
198%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.73-7.74
52W High
+8.43%
52W Low
+153%
RSI
73.87
Rel Volume
1.45
Avg Volume
30.04M
Volume
43.53M
Perf Week
0.53%
Perf Month
51.8%
Perf Quarter
67.92%
Perf Half Y
59.45%
-
-
-
-
Beta
1.423
-
-
Volatility
0.08%, 0.79%
Prev Close
0.66%
Price
7.59
Change
3.55%
3993.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.2 | 3.33 | 5.34 | 8.17 | 8.1 | |
| Net income per share | 0.21 | 0.09 | 0.11 | 0.24 | 0.28 | |
| Operating cash flow per share | 0.44 | 0.08 | 0.4 | 0.29 | 0.72 | |
| Free cash flow per share | 0.31 | -0.05 | 0.04 | 0.09 | 0.23 | |
| Cash per share | 1.27 | 1.13 | 1.15 | 1.48 | 1.73 | |
| Book value per share | 1.9 | 1.98 | 1.84 | 1.87 | 2.42 | |
| Tangible book value per share | 1.3 | 1.38 | 1.2 | 1.34 | 1.97 | |
| Share holders equity per share | 1.9 | 1.98 | 1.84 | 1.87 | 2.42 | |
| Interest debt per share | 1.44 | 2.22 | 2.21 | 2.28 | 2.39 | |
| Market cap | 54.59B | 61.53B | 90.86B | 71.36B | 67.9B | |
| Enterprise value | 57.65B | 89.87B | 118.94B | 93.91B | 83.6B | |
| P/E ratio | 11.78 | 33.14 | 39.02 | 13.98 | 11.19 | |
| Price to sales ratio | 2.1 | 0.9 | 0.8 | 0.41 | 0.39 | |
| POCF ratio | 5.79 | 36.09 | 10.7 | 11.53 | 4.39 | |
| PFCF ratio | 8.24 | -60.7 | 104.35 | 37.38 | 13.76 | |
| P/B Ratio | 1.33 | 1.51 | 2.34 | 1.79 | 1.31 | |
| PTB ratio | 1.33 | 1.51 | 2.34 | 1.79 | 1.31 | |
| EV to sales | 2.22 | 1.31 | 1.05 | 0.54 | 0.48 | |
| Enterprise value over EBITDA | 4.57 | 11.22 | 13.01 | 5.03 | 4.59 | |
| EV to operating cash flow | 6.11 | 52.72 | 14.01 | 15.17 | 5.41 | |
| EV to free cash flow | 8.7 | -88.65 | 136.61 | 49.19 | 16.94 | |
| Earnings yield | 0.08 | 0.03 | 0.03 | 0.07 | 0.09 | |
| Free cash flow yield | 0.12 | -0.02 | 0.01 | 0.03 | 0.07 | |
| Debt to equity | 0.73 | 1.08 | 1.16 | 1.18 | 0.94 | |
| Debt to assets | 0.29 | 0.38 | 0.37 | 0.34 | 0.29 | |
| Net debt to EBITDA | 0.24 | 3.54 | 3.07 | 1.21 | 0.86 | |
| Current ratio | 2.45 | 1.57 | 1.35 | 1.4 | 1.71 | |
| Interest coverage | 4.87 | 2.34 | 2.8 | 8.69 | 5.12 | |
| Income quality | 1.83 | 0.97 | 3.43 | 1.14 | 2.15 | |
| Dividend Yield | 0.05 | 0.07 | 0.03 | 0.03 | 0.07 | |
| Payout ratio | 0.57 | 2.26 | 1.13 | 0.48 | 0.79 | |
| Sales general and administrative to revenue | 0.02 | 0.01 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.21 | 0.18 | 0.18 | 0.14 | 0.12 | |
| Capex to operating cash flow | -0.3 | -1.59 | -0.9 | -0.69 | -0.68 | |
| Capex to revenue | -0.11 | -0.04 | -0.07 | -0.02 | -0.06 | |
| Capex to depreciation | -0.71 | -0.73 | -1.77 | -1.01 | -2.34 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.03 | 2 | 2.13 | 3.18 | 3.93 | |
| ROIC | 0.07 | 0.04 | 0.05 | 0.1 | 0.1 | |
| Return on tangible assets | 0.06 | 0.02 | 0.02 | 0.04 | 0.04 | |
| Graham Net | -0.81 | -1.4 | -1.67 | -1.84 | -1.98 | |
| Working capital | 23.19B | 19.6B | 14.88B | 20.3B | 35.62B | |
| Tangible asset value | 27.99B | 28.39B | 25.43B | 28.48B | 42.17B | |
| Net current asset value | -12.45B | -13.19B | -17.87B | -18.23B | -17.3B | |
| Invested capital | 0.73 | 1.08 | 1.16 | 1.18 | 0.94 | |
| Average receivables | 4.95B | 5.35B | 6.25B | 6.56B | 8.58B | |
| Average payables | 1.07B | 1.66B | 1.84B | 2.84B | 4.06B | |
| Average inventory | 6.16B | 13.67B | 20.95B | 24.07B | 29.61B | |
| Days sales outstanding | 62.56 | 33.21 | 20.19 | 14.43 | 21.69 | |
| Days payables outstanding | 25.9 | 12.12 | 5.25 | 9.65 | 9.2 | |
| Days of inventory on hand | 149.24 | 115.34 | 73.92 | 62.46 | 75.02 | |
| Receivables turnover | 5.83 | 10.99 | 18.08 | 25.3 | 16.83 | |
| Payables turnover | 14.09 | 30.13 | 69.47 | 37.81 | 39.66 | |
| Inventory turnover | 2.45 | 3.16 | 4.94 | 5.84 | 4.87 | |
| ROE | 0.11 | 0.05 | 0.06 | 0.13 | 0.12 | |
| Capex per share | -0.13 | -0.13 | -0.36 | -0.2 | -0.49 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.92 | 1.9 | 2.09 | 1.99 | 2.1 | |
| Net income per share | 0.05 | 0.04 | 0.01 | 0.02 | 0.08 | |
| Operating cash flow per share | 0.05 | 0.04 | 0.01 | 0.19 | 0.06 | |
| Free cash flow per share | -0.04 | -0.19 | -0.11 | 0.01 | -0.04 | |
| Cash per share | 2.2 | 1.73 | 1.83 | 1.99 | 2.04 | |
| Book value per share | 2.4 | 2.42 | 2.4 | 2.47 | 2.55 | |
| Tangible book value per share | 1.91 | 1.97 | 1.95 | 1.75 | 1.95 | |
| Share holders equity per share | 2.4 | 2.42 | 2.4 | 2.47 | 2.55 | |
| Interest debt per share | 2.76 | 2.3 | 2.26 | 2.59 | 2.81 | |
| Market cap | 58.99B | 67.9B | 87.79B | 80.98B | 100.17B | |
| Enterprise value | 78.01B | 83.6B | 104.08B | 100.1B | 122.75B | |
| P/E ratio | 12.74 | 22.31 | 69.21 | 52.44 | 14.39 | |
| Price to sales ratio | 1.45 | 1.68 | 1.98 | 1.91 | 2.23 | |
| POCF ratio | 50.94 | 89.22 | 276.85 | 19.66 | 74.88 | |
| PFCF ratio | -74.51 | -16.77 | -37.09 | 368.74 | -110.69 | |
| P/B Ratio | 1.16 | 1.31 | 1.73 | 1.53 | 1.84 | |
| PTB ratio | 1.16 | 1.31 | 1.73 | 1.53 | 1.84 | |
| EV to sales | 1.92 | 2.06 | 2.35 | 2.36 | 2.73 | |
| Enterprise value over EBITDA | 44.82 | 38.35 | 64.58 | 100.78 | 32.21 | |
| EV to operating cash flow | 67.37 | 109.85 | 328.2 | 24.3 | 91.75 | |
| EV to free cash flow | -98.54 | -20.64 | -43.97 | 455.84 | -135.64 | |
| Earnings yield | 0.02 | 0.01 | 0 | 0 | 0.02 | |
| Free cash flow yield | -0.01 | -0.06 | -0.03 | 0 | -0.01 | |
| Debt to equity | 1.13 | 0.94 | 0.92 | 1.03 | 1.08 | |
| Debt to assets | 0.34 | 0.29 | 0.29 | 0.3 | 0.32 | |
| Net debt to EBITDA | 10.93 | 7.2 | 10.1 | 19.26 | 5.92 | |
| Current ratio | 1.69 | 1.71 | 1.73 | 1.62 | 1.56 | |
| Interest coverage | 1.41 | 1.78 | 0.42 | 1.22 | 3.16 | |
| Income quality | 1 | 1 | 1 | 10.67 | 0.77 | |
| Dividend Yield | 0.04 | 0.02 | 0.01 | 0.01 | 0.03 | |
| Payout ratio | 1.98 | 2.13 | 3.15 | 2.4 | 1.6 | |
| Sales general and administrative to revenue | 0.03 | -0.02 | 0.01 | 0 | 0.03 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.12 | 0.12 | 0.12 | 0.14 | 0.14 | |
| Capex to operating cash flow | -1.68 | -6.32 | -8.46 | -0.95 | -1.68 | |
| Capex to revenue | -0.05 | -0.12 | -0.06 | -0.09 | -0.05 | |
| Capex to depreciation | 0.9 | -1.07 | 0 | -2.4 | 1.38 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.72 | 1.39 | 0.9 | 1 | 2.16 | |
| ROIC | 0.01 | 0.04 | 0 | 0 | 0.01 | |
| Return on tangible assets | 0.01 | 0.01 | 0 | 0 | 0.01 | |
| Graham Net | -1.76 | -1.98 | -1.98 | -2.35 | -2.26 | |
| Working capital | 38.79B | 35.62B | 34.83B | 33.79B | 32.91B | |
| Tangible asset value | 40.5B | 42.17B | 41.33B | 37.4B | 41.68B | |
| Net current asset value | -14.37B | -17.3B | -19.68B | -28.68B | -25.59B | |
| Invested capital | 1.13 | 0.94 | 0.92 | 1.03 | 1.08 | |
| Average receivables | 13.94B | 12.32B | 9.7B | 9.75B | 10.68B | |
| Average payables | 3.99B | 4.01B | 4.08B | 4.08B | 3.79B | |
| Average inventory | 28.42B | 31.02B | 30.9B | 31.15B | 33.82B | |
| Days sales outstanding | 31.74 | 22.83 | 18.52 | 22.03 | 21.98 | |
| Days payables outstanding | 9.4 | 9.43 | 8.9 | 8.78 | 8.26 | |
| Days of inventory on hand | 69 | 76.87 | 62.56 | 72.79 | 79.6 | |
| Receivables turnover | 2.84 | 3.94 | 4.86 | 4.09 | 4.09 | |
| Payables turnover | 9.57 | 9.54 | 10.11 | 10.25 | 10.9 | |
| Inventory turnover | 1.3 | 1.17 | 1.44 | 1.24 | 1.13 | |
| ROE | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | |
| Capex per share | -0.09 | -0.23 | -0.13 | -0.18 | -0.1 |
3993.HK Frequently Asked Questions
What is China Molybdenum Co., Ltd. stock symbol ?
China Molybdenum Co., Ltd. is a CN stock and trading under the symbol 3993.HK
What is China Molybdenum Co., Ltd. stock quote today ?
China Molybdenum Co., Ltd. stock price is $7.59 today.
Is China Molybdenum Co., Ltd. stock public?
Yes, China Molybdenum Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 30.04M
- Market Capitalization 199B
- Employee 12K
- CEO Mr. Ruiwen Sun
- Headquarters Luoyang,CN
- IPO Date 2007-04-26
-
Website
https://www.cmoc.com 
China Molybdenum Co., Ltd., together with its subsidiaries, engages in the mining, beneficiation, smelting, refining, and trading of copper, cobalt, molybdenum, tungsten, niobium, phosphates, and other base and rare metals. The company provides molybdenum oxide, ferromolybdenum, molybdenum and tungsten concentrates, copper concentrate, cobalt hydroxide, ferroniobium, phosphate fertilizer, gold and silver, and other related products. It is also involved in the refining and sale of mineral products; purchase and sale of molybdenum and tungsten products; import and export of goods and technology; and hotel management, consulting, enterprise operating and management, asset management, logistics, and transportation businesses. It has operations in China, Australia, Brazil and the Democratic Republic of the Congo, Switzerland, and internationally. China Molybdenum Co., Ltd. was incorporated in 2006 and is based in Luoyang, the People's Republic of China.
